PSNCBAM-1
Based on 1 Customer Validation
PSNCBAM-1 is a selective CB1 receptor allosteric antagonist with an EC50 of 0.1 μM. PSNCBAM-1 can be used in the researches of obesity.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.48%
- CAS 番号: 877202-74-9
- 分子式: C22H21ClN4O
- 分子量:392.88
-
保管条件:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
生物活性
|
hCB1-R 0.1 μM (EC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CHO | IC50 |
>10 μM
Compound: 2; PSNCBAM-1
|
Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by c
Antagonist activity at human CB2 receptor expressed in CHO cells co-expressing Galpha16 assessed as inhibition of EC80 CP55,940-induced calcium mobilization preincubated for 15 mins followed by CP55,490 addition measured at 1 sec interval for 90 secs by c
|
[PMID: 31596583] |
| CHO-K1 | EC50 |
3.84 nM
Compound: 2; PSNCBAM-1
|
Negative allosteric modulator activity at human CB1R expressed in CHO-K1 cells assessed as inhibition of CP55,940-induced beta-arrestin recruitment preincubated for 30 mins followed by CP55,940 addition measured for 90 mins by PathHunter assay
Negative allosteric modulator activity at human CB1R expressed in CHO-K1 cells assessed as inhibition of CP55,940-induced beta-arrestin recruitment preincubated for 30 mins followed by CP55,940 addition measured for 90 mins by PathHunter assay
|
[PMID: 26529344] |
| CHO-K1 | EC50 |
70.8 nM
Compound: 2; PSNCBAM-1
|
Negative allosteric modulator activity at human CB1R expressed in CHO-K1 cells assessed as effect on CP55,940-induced inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins followed by CP55,940 addition measured for 30 mins by HitHunte
Negative allosteric modulator activity at human CB1R expressed in CHO-K1 cells assessed as effect on CP55,940-induced inhibition of forskolin-induced cAMP accumulation preincubated for 30 mins followed by CP55,940 addition measured for 30 mins by HitHunte
|
[PMID: 26529344] |
| HEK293 | EC50 |
167 nM
Compound: 4, PSNCBAM-1
|
Displacement of [3H]CP55,940 from human CB1 receptor expressed in HEK293 cells after 1 hr by scintillation counting
Displacement of [3H]CP55,940 from human CB1 receptor expressed in HEK293 cells after 1 hr by scintillation counting
|
[PMID: 25162172] |
| HEK293 | IC50 |
1.47 nM
Compound: 2; PSNCBAM-1
|
Inverse agonist activity at human CB1 receptor expressed in HEK293 cell membranes assessed as suppression of [35S]GTPgammaS binding incubated for 60 mins by scintillation counting method
Inverse agonist activity at human CB1 receptor expressed in HEK293 cell membranes assessed as suppression of [35S]GTPgammaS binding incubated for 60 mins by scintillation counting method
|
[PMID: 31596583] |
| HEK293 | IC50 |
2620 nM
Compound: 2; PSNCBAM-1
|
Allosteric modulator activity at human CB1 receptor expressed in HEK293 cells assessed as suppression of 100 nM CP55,940-induced reduction in forskolin-stimulated cAMP production pre-incubated for 25 mins before forskolin and CP55,940 addition and measure
Allosteric modulator activity at human CB1 receptor expressed in HEK293 cells assessed as suppression of 100 nM CP55,940-induced reduction in forskolin-stimulated cAMP production pre-incubated for 25 mins before forskolin and CP55,940 addition and measure
|
[PMID: 31596583] |
| HEK293 | IC50 |
455 nM
Compound: 2; PSNCBAM-1
|
Allosteric modulator activity at human CB1 receptor expressed in HEK293 cell membranes assessed as suppression of 100 nM CP55,940-induced [35S]GTPgammaS binding incubated for 60 mins by scintillation counting method
Allosteric modulator activity at human CB1 receptor expressed in HEK293 cell membranes assessed as suppression of 100 nM CP55,940-induced [35S]GTPgammaS binding incubated for 60 mins by scintillation counting method
|
[PMID: 31596583] |
| U-937 | IC50 |
>10 μM
Compound: PSNCBAM-1
|
Inhibition of [ethanolamine-1-3H]AEA uptake in human U937 cell homogenate preincubated for 20 mins followed by AEA addition measured after 5 mins by scintillation counting method
Inhibition of [ethanolamine-1-3H]AEA uptake in human U937 cell homogenate preincubated for 20 mins followed by AEA addition measured after 5 mins by scintillation counting method
|
[PMID: 29079014] |
化学情報
-
CAS 番号 877202-74-9
-
性状 Solid
-
分子量 392.88
-
分子式 C22H21ClN4O
-
Color White to off-white
-
SMILES
ClC(C=C1)=CC=C1NC(NC2=CC=CC(C3=CC=CC(N4CCCC4)=N3)=C2)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
溶剤 & 溶解度
DMSO : 125 mg/mL (318.16 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (272 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5453 mL | 12.7265 mL | 25.4531 mL | 63.6327 mL |
| 5 mM | 0.5091 mL | 2.5453 mL | 5.0906 mL | 12.7265 mL | |
| 10 mM | 0.2545 mL | 1.2727 mL | 2.5453 mL | 6.3633 mL | |
| 15 mM | 0.1697 mL | 0.8484 mL | 1.6969 mL | 4.2422 mL | |
| 20 mM | 0.1273 mL | 0.6363 mL | 1.2727 mL | 3.1816 mL | |
| 25 mM | 0.1018 mL | 0.5091 mL | 1.0181 mL | 2.5453 mL | |
| 30 mM | 0.0848 mL | 0.4242 mL | 0.8484 mL | 2.1211 mL | |
| 40 mM | 0.0636 mL | 0.3182 mL | 0.6363 mL | 1.5908 mL | |
| 50 mM | 0.0509 mL | 0.2545 mL | 0.5091 mL | 1.2727 mL | |
| 60 mM | 0.0424 mL | 0.2121 mL | 0.4242 mL | 1.0605 mL | |
| 80 mM | 0.0318 mL | 0.1591 mL | 0.3182 mL | 0.7954 mL | |
| 100 mM | 0.0255 mL | 0.1273 mL | 0.2545 mL | 0.6363 mL |